Abstract
Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials.
Methods. A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements.
Results. OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains.
Conclusion. A revised core domain set will undergo further consensus-building.
Original language | English |
---|---|
Pages (from-to) | 1409-1414 |
Number of pages | 6 |
Journal | Journal of Rheumatology |
Volume | 46 |
Issue number | 10 |
DOIs | |
Publication status | Published - 1 Oct 2019 |
Event | International Consensus Conference on Outcome Measures in Rheumatology (OMERACT) - Terrigal, Australia Duration: 1 May 2018 → … |
Keywords
- OMERACT
- RHEUMATIC DISEASES
- OUTCOMES
- EULAR RECOMMENDATIONS
- RHEUMATOID-ARTHRITIS
- TRIALS
- MANAGEMENT
- AIDS
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Rheumatology, Vol. 46, No. 10, 01.10.2019, p. 1409-1414.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions
AU - Toupin-April, Karine
AU - Barton, Jennifer L.
AU - Fraenkel, Liana
AU - Meara, Alexa
AU - Li, Linda C.
AU - Brooks, Peter
AU - de Wit, Maarten
AU - Stacey, Dawn
AU - Legare, France
AU - Shea, Beverley
AU - Lyddiatt, Anne
AU - Hofstetter, Cathie
AU - Christensen, Robin
AU - Voshaar, Marieke Scholte
AU - Suarez-Almazor, Maria E.
AU - Boonen, Annelies
AU - Meade, Tanya
AU - March, Lyn
AU - Jull, Janet Elizabeth
AU - Campbell, Willemina
AU - Alten, Rieke
AU - Karuranga, Suvi
AU - Morgan, Esi M.
AU - Kelly, Ayano
AU - Kaufman, Jessica
AU - Hill, Sophie
AU - Maxwell, Lara J.
AU - Beaton, Dorcas
AU - El-Miedany, Yasser
AU - Mittoo, Shikha
AU - Bartlett, Susan J.
AU - Singh, Jasvinder A.
AU - Tugwell, Peter S.
N1 - Funding Information: From the Children’s Hospital of Eastern Ontario Research Institute; Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa; School of Nursing, University of Ottawa; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Ottawa Hospital Research Institute, Centre for Practice-Changing Research; Clinical Epidemiology Program, Ottawa Hospital Research Institute; School of Rehabilitation Therapy, Queen’s University, Kingston; Toronto Western Hospital, University Health Network; Institute for Work & Health; Institute of Health Policy, Management and Evaluation, University of Toronto; Involved Medicine, University of Toronto, Toronto, Ontario; Department of Physical Therapy, University of British Columbia; Arthritis Research Canada, Vancouver, British Columbia; Department of Family Medicine and Emergency Medicine, Université Laval, Quebec City; McGill University, Montreal, Quebec, Canada; Portland Health Care System; Oregon Health & Science University, Portland, Oregon; Department of Internal Medicine, Yale University, New Haven, Connecticut; The Ohio State University, Columbus; Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; University of Alabama at Birmingham, Birmingham, Alabama, USA; School of Population and Global Health, University of Melbourne; Centre for Health Communication and Participation, School of Psychology and Public Health, La Trobe University, Melbourne; Western Sydney University; Faculty of Medicine, University of Sydney; Department of Medicine, University of Sydney, Institute of Bone and Joint Research; Department of Rheumatology, Royal North Shore Hospital, Sydney; Canberra Rheumatology, Department of Rheumatology, Canberra Hospital; College of Health and Medicine, Australian National University, Canberra, Australia; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam; Department of Psychology, Health and Technology, University of Twente, Enschede; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; Caphri Research Institute, Maastricht University, Maastricht; Access to Medicine Foundation, Haarlem, the Netherlands; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Department of Internal Medicine II, Rheumatology Research Center, Rheumatology, Clinical Immunology, Osteology, Physical Therapy and Sports Medicine, Schlosspark-Klinik, Charité, University Medicine Berlin, Berlin, Germany; Rheumatology and Rehabilitation Ain Shams University, Cairo, Egypt; King’s College London, London, UK. K. Toupin-April is funded by the Children’s Hospital of Eastern Ontario Research Institute and The Arthritis Society. J.L. Barton’s research reported in this publication was supported by the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), under Award Number K23-AR-064372. L. Fraenkel’s research reported in this publication was supported by NIAMS, part of the NIH, under Award Number AR060231-01. D. Stacey holds a University of Ottawa Research Chair in Knowledge Translation to Patients. F. Légaré holds a Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation. R. Christensen’s research at the Parker Institute is supported by grants from The Oak Foundation (OCAY-13-309). L. March’s research is supported by the Northern Sydney Local Health District. S. Hill is supported by La Trobe University. P.S. Tugwell holds a Canada Research Chair. K. Toupin-April, PhD, Associate Scientist, Children’s Hospital of Eastern Ontario Research Institute, and Assistant Professor, Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa; J.L. Barton, MD, VA Portland Health Care System, and Associate Professor, Oregon Health & Science University; L. Fraenkel, MD, Professor of Medicine, Department of Internal Medicine, Yale University; A. Meara, MD, The Ohio State University; L.C. Li, PT, PhD, Professor, Department of Physical Therapy, University of British Columbia, and Senior Scientist, Arthritis Research Canada; P. Brooks, MD, Professor, School of Population and Global Health, University of Melbourne; M. de Wit, PhD, Patient Research Partner, Amsterdam University Medical Centre, Department of Medical Humanities; D. Stacey, RN, PhD, Full Professor, School of Nursing, University of Ottawa, and Senior Scientist, Funding Information: K. Toupin-April is funded by the Children?s Hospital of Eastern Ontario Research Institute and The Arthritis Society. J.L. Barton?s research reported in this publication was supported by the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), under Award Number K23-AR-064372. L. Fraenkel?s research reported in this publication was supported by NIAMS, part of the NIH, under Award Number AR060231-01. D. Stacey holds a University of Ottawa Research Chair in Knowledge Translation to Patients. F. L?gar? holds a Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation. R. Christensen?s research at the Parker Institute is supported by grants from The Oak Foundation (OCAY-13-309). L. March?s research is supported by the Northern Sydney Local Health District. S. Hill is supported by La Trobe University. P.S. Tugwell holds a Canada Research Chair. The authors thank members of the working group: Laure Gossec, Sarah Collins, Thomas Chong, Pamela Richards, Ailsa Bosworth, Pamela Montie, Francis Guillemin, Jennifer Petkovic, Melissa Mannion, C?cile Gaujoux-Viala, Anne Stiggelbout, and Nick Bansback. Finally, we thank the study participants. Publisher Copyright: The Journal of Rheumatology Copyright © 2019. All rights reserved.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials.Methods. A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements.Results. OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains.Conclusion. A revised core domain set will undergo further consensus-building.
AB - Objective. The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials.Methods. A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements.Results. OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains.Conclusion. A revised core domain set will undergo further consensus-building.
KW - OMERACT
KW - RHEUMATIC DISEASES
KW - OUTCOMES
KW - EULAR RECOMMENDATIONS
KW - RHEUMATOID-ARTHRITIS
KW - TRIALS
KW - MANAGEMENT
KW - AIDS
U2 - 10.3899/jrheum.181071
DO - 10.3899/jrheum.181071
M3 - Article
C2 - 30709963
SN - 0315-162X
VL - 46
SP - 1409
EP - 1414
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 10
T2 - International Consensus Conference on Outcome Measures in Rheumatology (OMERACT)
Y2 - 1 May 2018
ER -